Reuters logo
BRIEF-Histogenics Corp announces Q3 loss per share $0.23
2017年11月9日 / 下午12点47分 / 9 天前

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

Nov 9 (Reuters) - Histogenics Corp

* Histogenics Corporation announces third quarter 2017 financial and operating results

* Q3 loss per share $0.23

* Q3 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S

* Histogenics Corp - ‍Potential biologics license application filing remain on track for Q3 of 2018​

* Histogenics Corp - ‍Believes its current cash position will be sufficient to fund its operations into middle of 2018​

* Histogenics - ‍As of September 30, 2017, co had cash, cash equivalents and marketable securities of $12.6 million, compared to $31.9 million at December 31, 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below